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A new somatostatin-28 has been isolated from the Teleostean fish (Lophiuspiscatorius) Brockmann organs. 
Determination of its aminoacid sequence indicates that it corresponds to an octacosapeptide containing in 
its C-terminal end the Tyr-7 Gly-10 derivative of somatostatin-14 I. This structure is in agreement with the 
one predicted by Hobart et al. (Nature (1980) 288, 137-141) from a cDNA nucleotide sequence. It demon- 
strates that, since the corresponding somatostatin-14 II cannot be detected in this organ, S-28 II is a terminal 
product of prosomatostatin II processing in anglerlish pancreatic islets. 
Amino-acid sequencing Anglerfish Somatostatin-28 II Somatostatin-14 I Pancreatic islet 
1. INTRODUCTION 
The Brockmann organ from the teleostean fish 
Lophiuspiscatorius is an endocrine pancreas tissue 
[3] containing large amounts of somatostatin 
material [4]. Expression of gene coding for this 
peptide has been the subject of several investiga- 
tions [5,6]. In 1980, Rutter and his collaborators 
cloned two cDNA corresponding to two mRNA 
species from this organ [7]. The nucleotide se- 
quences of these DNA indicated that one of the 
two polymers encodes a prosomatostatin contain- 
ing, at its C-terminal end, a new tetradecapeptide 
called somatostatin-14 II [7]. This sequence cor- 
Abbreviations: DABSCI, dimethylaminoazobenzene 
sulphonyl chloride; DABITC, 4-N,N-dimethylamino- 
benzene 4’isothiocyanate; PITC, phenylisothiocyanate; 
HPLC, High Performance Liquid Chromatography; 
PTH, phenylthiohydantoin 
responds to the Tyr-7, Gly-10 derivative of the 
somatostatin-14 I found in the brain and in pan- 
creatic tissues [8]. Attempts to detect this second 
variety of somatostatin-14 both in neural and pan- 
creatic tissues remained unsucessful [9, lo]. How- 
ever, results by others indicated that this tetradeca- 
peptide could be included into a larger form deriv- 
ing from the corresponding precursor, prosomato- 
statin II [l 11. We have recently shown that angler- 
fish Brockmann organs contain a single species of 
S-14 indistinguishable from S-14 I of both hypo- 
thalamic and pancreatic tissues [4]. In contrast, 
analysis by HPLC of the S-28 forms indicated that 
two distinct forms could be separated [4]. Both im- 
munochemical and biochemical evidences [4] have 
shown that one of the two species could corres- 
pond to S-28 II, the C-terminal octacosapeptide 
fragment of prosomatostatin II, including the 
Tyr-7, Gly-10 derivative of somatostatin-14 I. 
Moreover, exposure of this new somatostatin-28 to 
an Arg-Lys-esteropeptidase preparation from the 
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rat brain cortex [ 121 led to quantitative conversion 
into a tetradecapeptide identified as somatos- 
tatin- II by HPLC [4]. 
In the present report we demonstrate that this 
hypothesis is indeed correct by determining the 
complete amino acid sequence of the isolated pep- 
tide. 
2. MATERIALS AND METHODS 
Somatostatin-28 II was extracted from angler- 
fish pancreatic islets freshly collected from live 
animals on the fishing boat (thanks to the kind 
hospitality of Captain Riou and his crew, La 
Marie-Sophie, Le Conquet, Finistere, France). 
This peptide was purified by successive HPLC 
steps using a reverse phase lORP8 Lichrosorb col- 
umn (Merck) eluted by a mixture of acetonitrile/ 
trifluoroacetic acid 19ko (v/v) in HzO/trifluoroace- 
tic acid 1% (v/v). A linear gradient from 28 to 
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Fig. 1. Purification by HPLC of somatostatin-28 II 
isolated from anglerfish Brockmann organs. The S-28 
species recovered from a Sephadex G-50 column frac- 
tionation [4] were first submitted to reverse-phase 
HPLC on a lORP8 column (4 x 250 mm) eluted with a 
mixture of acetonitrile/trifluoroacetic acid 19bo (v/v) in 
HzO/trifluoroacetic acid l%o (v/v). A linear gradient 
from 28 to 33% acetonitrile was employed at 1 ml. 
min-’ for 30 min. This operation was repeated with the 
same methodology. A typical result is shown. The trace 
represents elution of the isolated S-28 II previously 
separated from S-28 I, monitored at 215 nm as a func- 
tion of the retention time. 
33% acetonitrile was employed at 1 ml. min-’ for 
30 min. This operation was repeated, using the 
same methodology, until complete separation of 
somatostatin-28 II was achieved. The HPLC 
system consisted in a Spectra Physics (SP 8000) 
system, and a Kratos SF740 uv detector (Schoeffel) 
was used for monitoring peptides in the column ef- 
fluent. 
N-terminal analysis was performed by the 
manual double coupling method of Chang [ 131 us- 
ing DABITWPITC (from Fluka, Switzerland). 
The amino acid composition was determined on a 
hydrolysate of the peptide after derivatization of 
the released residues by DABSCl ([ 141; Fluka) 
followed by HPLC analysis of the derivatives [151. 
Fragmentation was accomplished on 1 nmol of the 
peptide, using endolysine as protease (Boehringer, 
FRG). Automatic sequencing was carried out by a 
gas-phase U70A protein sequanator using program 
Q provided by Applied Biosystems [16]. PTH 
amino acids were then analyzed by HPLC accor- 
ding to [17]. 
3. RESULTS AND DISCUSSION 
The isolated peptide was found homogeneous by 
HPLC criteria (see fig. 1) and N-terminal amino 
Table 1 
Amino acid composition of anglerfish Somatostatin-28 
II 
Amino acid Found residues 
per mol 
Theoretical 
Asp 3.7 4 
Glu 1.3 1 
Ser 3 3 
Thr 1.8 2 
ClY 1.8 2 
Ala 0.9 1 
Arg 1.7 2 
Pro 1.7 2 
Val 0.7 1 
Leu 1.2 1 
Phe 2 2 
Cys n.d. 2 
Lys 2.6 3 
Tyr 1.3 1 
Trp n.d. 1 
n.d., not determined. 
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acids analysis. The amino acid composition, deter- this l-12 moiety either plays a role in the overall 
mined on an hydrolysate using the HPLC separa- conformation of the octacosapeptide or else as 
tion of the DABSCI derivatives [15], was in good such if released. It provides also suggestive, but 
agreement with the theoretical one (table 1). It indirect evidence in favor of a processing of pro- 
showed in particular the presence of a tyrosine and somatostatin via the S-28 form. That this latter oc- 
of an extra glycine residue. The complete sequence tacosapeptide is not simply an intermediate in the 
was determined using the following strategy. First- prosomatostatin -S-14 conversion and does not 
ly, the intact peptide was analyzed by the manual 
double-coupling method [ 131 and the residues Set-‘, 
work simply as a precursor of the tetradecapeptide 
Val’, Asp3, Ser4 and Thr’ were determined. 
is suggested by direct binding studies [21]. 
The exact biological function of this 
Secondly, the peptide was digested with endolysine 
which generates four fragments corresponding to 
cleavage at Lysr4, Lys18, LYS~~ and the fragments 
were analyzed for their N-terminal end by three 
successive cycles of the Chang double coupling 
method [13]. Ser’, Ala15, Asnrg, Gly24 then Va12, 
Gly16, Phe2’ and Phe25, then Asp3, Tyr21 and Thr26 
were found in the successive cycles. 
Third, the complete amino acid sequence was 
determined by automated Edman degradation 
followed by HPLC analysis of the PTH 
derivatives. 
The deduced sequence is the following: 
somatostatin-28 II remains to be discovered in the 
gastrointestinal tract of the anglerfish. 
ACKNOWLEDGEMENTS 
This work was supported in part by funds from 
the Universite Pierre et Marie Curie, the Centre 
National de la Recherche Scientifique (UA ‘No. 
554), the Fondation pour la Recherche Medicale 
Francaise and the Institut National de la Sante et 
de la Recherche Medicale (INSERM, CRE No. 
834006). 
5 10 
Ser Val Asp Ser Thr Asn Asn Leu Pro Pro Arg Glu Arg Lys 
-_) -_) -+ -_) + * + -+ + + + + * + 
15 20 25 
Ala Gly Cys Lys Asn Phe Tyr Trp Lys Gly Phe Thr Ser Cys 
+ + + -+ + + * -+ + + -_, + -_) 
I I ______ _---__- 
As can be observed Tyr21 and Gly” substitute 
the usual Phe” and Thr= of the somatostatins 28 
from both mammalian pancreas and hypothala- 
mus [ 1 S-201. 
Much wider discrepancies were found in the N- 
terminal half of the molecule (1+12 portion) 
upstream from the Arg” Lys16 doublet. Substitu- 
tions at positions 2,3,5,6,7,8,9 were found when 
compared to the mammalian octacosapeptide 
[ 18-201. Since this new peptide exhibits, in an 
heterologous ystem [4], a strong biological poten- 
cy (inhibition of growth hormone release by rat 
anterior pituitary cells), this raises interesting ques- 
tions about the putative biological role of the S-28 
II (1 + 12) fragment. The fact that in vivo the oc- 
tacosapeptide does not generate the corresponding 
S-14 II terminal fragment does not exclude that 
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